JFL Life Sciences Ltd

JFL Life Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

JFL Life Sciences Ltd

₹ 22.2 3.50%
20 May - close price
jfllifesciences.com NSE - SME: JFLLIFE
About

Incorporated in 2010, JFL Life Sciences Ltd produces and markets a wide range of formulations[1]

Key Points

Business Overview:[1]
JFLLSL is a WHO-GMP Certified pharmaceutical company that manufactures and sells products across multiple markets. It specializes in Dry Powder Injectable Solid Oral Dosage Forms (Beta-Lactam & General)

Website NSE - SM
  • Market Cap ₹ 73.2 Cr.
  • Current Price ₹ 22.2
  • High / Low ₹ 37.2 / 12.3
  • Stock P/E 17.6
  • Book Value ₹ 12.0
  • Dividend Yield 0.38 %
  • ROCE 15.8 %
  • ROE 11.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has a low return on equity of 11.0% over last 3 years.
  • Company has high debtors of 155 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2024 Dec 2024 Mar 2025
21.70 21.25 11.73
20.15 19.90 10.35
Operating Profit 1.55 1.35 1.38
OPM % 7.14% 6.35% 11.76%
0.02 0.00 0.00
Interest 0.09 0.20 0.33
Depreciation 0.11 0.16 0.36
Profit before tax 1.37 0.99 0.69
Tax % 13.14% 25.25% 86.96%
1.19 0.74 0.08
EPS in Rs 0.36 0.22 0.02
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
31.78 30.17 32.77 33.59 42.83 46.55 82.04
30.45 28.31 30.61 28.23 38.91 42.00 73.84
Operating Profit 1.33 1.86 2.16 5.36 3.92 4.55 8.20
OPM % 4.19% 6.17% 6.59% 15.96% 9.15% 9.77% 10.00%
0.00 0.03 0.09 0.89 1.64 0.52 0.01
Interest 0.75 1.16 1.23 2.08 1.42 0.83 1.08
Depreciation 0.15 0.24 0.28 0.37 0.43 0.44 0.99
Profit before tax 0.43 0.49 0.74 3.80 3.71 3.80 6.14
Tax % 27.91% 28.57% 27.03% 26.05% 24.53% 13.16% 32.25%
0.30 0.36 0.54 2.81 2.81 3.31 4.16
EPS in Rs 2.31 2.77 2.84 1.17 0.85 1.00 1.26
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 8.31% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 22%
3 Years: 35%
TTM: 76%
Compounded Profit Growth
10 Years: %
5 Years: 63%
3 Years: 14%
TTM: 26%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 59%
Return on Equity
10 Years: %
5 Years: 13%
3 Years: 11%
Last Year: 11%

Balance Sheet

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.42 0.42 0.50 8.02 11.00 11.00 33.00
Reserves 4.59 4.95 6.38 3.27 21.27 24.58 6.46
8.41 9.33 16.82 15.85 7.18 5.69 10.59
2.73 9.63 5.31 21.12 9.60 15.37 21.86
Total Liabilities 16.15 24.33 29.01 48.26 49.05 56.64 71.91
2.48 5.05 6.50 7.13 6.80 12.47 12.24
CWIP 0.04 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
13.63 19.28 22.51 41.13 42.25 44.17 59.67
Total Assets 16.15 24.33 29.01 48.26 49.05 56.64 71.91

Cash Flows

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-3.00 3.21 -5.87 2.32 -9.07 8.36 -3.53
-0.61 -2.76 -1.64 -0.71 0.87 -6.07 -0.01
3.61 -0.19 7.25 -1.46 8.07 -2.31 3.54
Net Cash Flow 0.00 0.27 -0.26 0.15 -0.13 -0.03 0.00

Ratios

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 110.95 153.16 131.54 215.15 191.58 197.20 155.49
Inventory Days 21.43 51.75 72.47 211.64 130.01 148.72 128.31
Days Payable 17.79 121.71 57.70 218.43 75.53 92.17 98.05
Cash Conversion Cycle 114.58 83.20 146.31 208.36 246.06 253.76 185.75
Working Capital Days 125.65 103.80 170.30 197.44 270.58 218.22 169.20
ROCE % 11.74% 10.26% 23.13% 15.41% 11.47% 15.81%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025
67.47% 67.47% 67.47% 67.47% 67.47% 67.47% 67.47%
32.53% 32.53% 32.54% 32.53% 32.53% 32.53% 32.53%
No. of Shareholders 978921873832825966997

Documents

Announcements

Annual reports